Royce & Associates LP Acquires 9,519 Shares of Patterson Companies, Inc. (NASDAQ:PDCO)

Royce & Associates LP lifted its holdings in Patterson Companies, Inc. (NASDAQ:PDCO - Free Report) by 3.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 321,201 shares of the company's stock after purchasing an additional 9,519 shares during the quarter. Royce & Associates LP owned 0.36% of Patterson Companies worth $9,912,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of PDCO. BNP Paribas Financial Markets raised its position in Patterson Companies by 31.5% in the 3rd quarter. BNP Paribas Financial Markets now owns 33,257 shares of the company's stock worth $726,000 after buying an additional 7,969 shares during the last quarter. Equity Investment Corp raised its holdings in shares of Patterson Companies by 10.6% during the third quarter. Equity Investment Corp now owns 1,739,669 shares of the company's stock valued at $37,994,000 after purchasing an additional 166,899 shares during the last quarter. Goodman Financial Corp raised its holdings in shares of Patterson Companies by 19.1% during the third quarter. Goodman Financial Corp now owns 543,282 shares of the company's stock valued at $11,865,000 after purchasing an additional 86,972 shares during the last quarter. Mork Capital Management LLC lifted its position in Patterson Companies by 142.9% during the third quarter. Mork Capital Management LLC now owns 84,980 shares of the company's stock valued at $1,856,000 after purchasing an additional 50,000 shares during the period. Finally, Barclays PLC boosted its holdings in Patterson Companies by 37.2% in the third quarter. Barclays PLC now owns 165,715 shares of the company's stock worth $3,619,000 after purchasing an additional 44,906 shares during the last quarter. 85.43% of the stock is owned by institutional investors.

Remove Ads

Patterson Companies Price Performance

Shares of PDCO stock traded down $0.03 on Friday, hitting $31.16. 2,160,892 shares of the stock traded hands, compared to its average volume of 1,016,032. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.37 and a quick ratio of 0.76. Patterson Companies, Inc. has a 52 week low of $19.45 and a 52 week high of $31.79. The firm has a 50 day simple moving average of $31.03 and a two-hundred day simple moving average of $26.11. The firm has a market cap of $2.76 billion, a price-to-earnings ratio of 18.22, a PEG ratio of 2.71 and a beta of 0.99.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. StockNews.com initiated coverage on Patterson Companies in a report on Wednesday. They set a "hold" rating on the stock. Stifel Nicolaus dropped their target price on Patterson Companies from $25.00 to $24.00 and set a "hold" rating on the stock in a research report on Thursday, December 5th. Morgan Stanley boosted their price target on Patterson Companies from $27.00 to $31.35 and gave the company an "equal weight" rating in a research note on Tuesday, December 17th. Mizuho initiated coverage on shares of Patterson Companies in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $23.00 price objective on the stock. Finally, Piper Sandler cut their target price on shares of Patterson Companies from $26.00 to $24.00 and set a "neutral" rating for the company in a research report on Friday, December 6th. Eleven research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $26.57.

Patterson Companies Company Profile

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.